Učitavanje...

Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment

Advances in cancer immunity have promoted a major breakthrough in the field of cancer therapy. This is mainly associated with the successful development of immune checkpoint inhibitors (ICIs) for multiple types of human tumors. Blockade with different ICIs, including programmed cell death 1 (PD-1),...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Immunol
Glavni autori: Song, Yuxiao, Fu, Yang, Xie, Qi, Zhu, Bo, Wang, Jun, Zhang, Bicheng
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7477085/
https://ncbi.nlm.nih.gov/pubmed/32983126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01956
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!